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Background: To evaluate the volumetric and geometric differences in the ITVs generated by four-dimensional (4D)
computed tomography (CT), a modified slow CT scan, and a combination of these CT methods in lung cancer
patients treated with stereotactic body radiotherapy (SBRT).
Methods: Both 4D CT and modified slow CT using a multi-slice CT scanner were performed for SBRT planning in
14 patients with 15 pulmonary targets. Volumetric and geometric analyses were performed for (1) ITVall, generated
by combining the gross tumor volumes (GTVs) from all 8 phases of the 4D CT; (2) ITV2, generated by combining
the GTVs from 2 extreme phases of the 4D CT; (3) ITVslow, derived from the GTV on the modified slow CT scan;
(4) ITVall+slow, generated by combining ITVall and ITVslow; and (5) ITV2+slow, generated by combining ITV2 and
ITVslow. Three SBRT plans were performed using 3 ITVs to assess the dosimetric effects on normal lung caused by
the various target volumes.
Results: ITVall (11.8 ± 8.3 cm3) was significantly smaller than ITVall+slow (12.5 ± 8.9 cm3), with mean values of 5.8%
for the percentage volume difference, and a mean of 7.5% of ITVslow was not encompassed in ITVall. The geometric
coverages of ITV2 and ITVslow for ITVall were 84.7 ± 6.6% and 76.2 ± 9.3%, respectively, but the coverage for ITVall
increased to 90.9 ± 5.9% by using the composite of these two ITVs. There were statistically significant increases in the
lung-dose parameters of the plans based on ITVall+slow compared to the plans based on ITVall or ITV2+slow. However,
the magnitudes of these differences were relatively small, with a value of less than 3% in all dosimetric parameters.
Conclusions: Due to its ability to provides additional motion information, the combination of 4D CT and a modified
slow CT scan in SBRT planning for lung cancer can be used to reduce possible errors in true target delineation caused
by breathing pattern variations.
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Stereotactic body radiotherapy (SBRT) has been widely
adopted for medically inoperable early-stage non-small
cell lung cancer (NSCLC) and metastatic lung cancer with
high local control rate of > 80% and acceptable toxicity in
most studies [1]. In addition, for centrally located tumors
in the lung, SBRT can be feasible with a less aggressive
dose regimen and the exclusion of critical structures from
the high-dose region. Despite promising results in medic-
ally inoperable patients, the role of SBRT in treating oper-
able NSCLC remains to be defined by ongoing randomized
trials. This approach involves the delivery of an ablative
dose to the target using highly conformal and hypofractio-
nated radiation over a short time course. In radiotherapy
for lung cancer, large uncertainties exist in target delin-
eation and localization because of respiration-induced
tumor motion. These uncertainties are particularly influen-
tial in the SBRT technique, which uses high doses in small
fractions for a small target volume.
The magnitude of respiration-induced tumor motion in
the lung can be greater than 2 cm depending on the tumor
location and the patient. In fact, this motion exhibits a clear
patient-specific aspect, as it is difficult to estimate the range
of motion before actual measurements [2-4]. The Inter-
national Commission on Radiation Units and Measure-
ments (ICRU) Report 62 introduced the concept of an
internal target volume (ITV), which consists of the clinical
target volume (CTV) with the addition of an internal mar-
gin to account for tumor motion [5]. In addition, the
American Association of Physicists in Medicine (AAPM)
has produced a report on methods for reducing the impact
of respiratory motion, including motion-encompassing
methods [6]. Individualized ITVs that encompass the entire
range of respiratory tumor motion can be effectively con-
structed using the following three computed tomography
(CT) acquisition methods: slow CT, inhalation and exhal-
ation breath-hold CT, and four-dimensional (4D) CT scans.
Slow CT involves scanning using a slow gantry rotation
speed to ideally capture the full range of tumor motion
within each slice, while producing blurred images of
moving objects [6]. Recently, an adaptation of the 4D
CT technique allowed for the acquisition of 3D CT im-
ages at multiple phases of the respiratory cycle. This
capability has proven very useful in the planning of
radiotherapy by considering the respiratory motions of
the tumor and organs [7]. The use of data from a 4D
CT scan, which is the gold standard for ITV delineation, is
also strongly recommended for SBRT planning in the case
of lung cancer [8]. There are several methods for using 4D
CT data to generate individualized ITVs [4,9]. One time-
consuming method, which may be the most accurate
method of acquiring ITVs using 4D CT, is the delineation
of a composite volume that encompasses the gross tumor
volumes (GTVs) in all respiratory phase bins. A useful toolfor reducing the clinical workload involved in contouring
on all 4D CT phases is to use the maximum intensity pro-
jection (MIP) dataset or only the 2 extreme phases of the
4D CT scan.
However, these methods based on a single 4D CT scan,
which is sampled from just a few breathing cycles, might
underestimate the full extent of the true tumor motion
during treatment due to possible variations in the patient’s
breathing pattern [4,10]. Despite breath coaching to en-
sure a regular breathing pattern or motion monitoring at
the time of treatment with image guidance techniques,
differences in breathing patterns between the 4D CT plan-
ning and the treatment delivery can lead to geometric
errors. In addition to techniques for regular breathing and
image guidance, studies have compared the differences
in target volumes obtained using different CT scan
techniques for patients with lung cancer [11-15]. The
addition of motion information from an additional CT
scan method might serve to reduce the risk caused by
breathing pattern variations. As an attempt to develop a
more accurate ITV delineation method in SBRT planning
for lung cancer, we focused on the combined use of 4D
CT and a modified slow CT scan. The present study was
undertaken to evaluate the volumetric and geometric
differences in the ITVs generated by 4D CT, a modified
slow CT, and the combination of these CT methods in
lung cancer patients treated with SBRT. In addition, the
dosimetric consequences for lung organs at risk (OAR)
in SBRT planning using various ITV definitions were
compared for these patients.
Methods
Patient characteristics
With the approval (DIRB-00102_1-002) of the institutional
review board of Daejeon St. Mary's Hospital, 15 tumors
in 14 patients treated with SBRT for early-stage NSCLC
(13 tumors) or pulmonary metastases (2 tumors) at our
institution between December 2009 and June 2013 were
included in this retrospective study. The median age of
the patients was 66 years (range: 55–86 years), and the
sample included 13 males and 1 female. The tumor location
was the upper lobe for 9 tumors, the middle lobe for 1
tumor, and the lower lobe for 5 tumors. Of these 15
tumors, 14 tumors were peripherally located and 1 tumor
was centrally located.
CT data acquisition and tumor motion analysis
Both 4D CT and modified slow CT techniques using a
multi-slice CT scanner (SOMATOM Sensation 64; Siemens
Medical Solutions, Erlangen, Germany) were performed for
SBRT planning in all patients. Patients were advised to
breathe freely and regularly. First, a single helical 4D
CT scan including the whole lung was acquired with
fixed acquisition parameters (pitch of 0.1, rotation time
Table 1 Summary of different ITVs and investigated
parameters for volumetric and dosimetric changes
ITV Definition
ITVall Volume generated by combining the GTVs from all
8 phases of 4D CT
ITV2 Volume generated by combining the GTVs from 2
extreme phases of 4D CT
ITVslow Volume derived from the GTV on a modified slow
CT scan
ITVall+slow Volume generated by combining ITVall and ITVslow
ITV2+slow Volume generated by combining ITV2 and ITVslow
Change Parameter
Volume Absolute volume, PVD
Shape/Location POV, Geometric coverage (Missing volume) for a
specific ITV
Lung-dose MLD, V5, V10, V20, V25, V30
Abbreviations: ITV internal target volume; GTV gross tumor volume; 4D CT
four-dimensional computed tomography; PVD percentage volume difference;
POV percentage of overlap volume, defined as the ratio between the overlapping
and encompassing volume; MLD mean lung dose; V5, V10, V20, V25, and V30,
percentage volumes of both lungs minus the PTV receiving more than 5, 10, 20,
25, and 30 Gy.
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available motion-monitoring system (AZ-733 V; Anzai
Medical, Tokyo, Japan). A pressure sensor (AZ-733 V)
fixed in the upper abdominal region by means of an
elastic belt generated the external respiratory signal. A
lower signal amplitude (low pressure) corresponds to the
exhalation phase, and a higher amplitude (high pressure)
corresponds to the inhalation phase of the breathing cycle.
Abdominal compression for the reduction of breathing
motion was not applied for any patient. Using the Syngo
software package (Siemens Medical Solutions), the projec-
tions were sorted retrospectively based on the respiratory
signal, and the images were reconstructed into 8 respira-
tory phase bins equally distributed over the breathing
cycle, with a slice thickness of 3.0 mm. Immediately fol-
lowing the 4D CT scan, a modified slow CT scan with the
same scan range and slice thickness was performed with
the same scanner, using the longest possible gantry rota-
tion time, 1.0 s, and a reduced pitch factor of 0.5 [16]. The
amplitude of the tumor motion was determined by meas-
uring the tumor movement in the 8-phase 4D CT datasets
using the InSpace 4D software package (Siemens Medical
Solutions). The motion ranges at the tumor centroid in
the superior-inferior (SI), anterior-posterior (AP), and
left-right (LR) directions were measured in the transverse,
sagittal, and coronal planes with a grid spacing of 1 mm
for all 8 phase bins registered by this software.
Target volume definitions
All CT datasets were transferred into a commercial
treatment-planning system (Pinnacle3 version 8.0 m; Philips
Medical Systems, Fitchburg, WI, USA), and thereafter, the
4D CT and modified slow CT images were superimposed
using an automated algorithm of the Syntegra® software
package (Philips Medical Systems). Match results were
visually verified by reviewing the alignment of the spinal
vertebrae. GTVs in each of the 8 phases of the 4D CT
image were delineated using lung window setting by the
same radiation oncologist and projected onto the modified
slow CT image of the same slice. We used 5 approaches
to define the ITVs: (1) combining the GTVs from all
8 phases of the 4D CT (ITVall); (2) combining the
GTVs from 2 extreme phases (end-exhalation and end-
inhalation) of the 4D CT (ITV2); (3) contouring the GTV
on the modified slow CT scan (ITVslow); (4) combining
ITVall and ITVslow (ITVall+slow); and (5) combining
ITV2 and ITVslow (ITV2+slow) (Table 1).
Volumetric and geometric analyses
Five target volumes obtained using different ITV
definitions were measured for each of the 15 tumors,
and the percentage volume difference (PVD), defined
as |Va - Vb| / Va, between each pair of ITVs was also cal-
culated. In addition to these volumetric differences, thefollowing parameters were measured to compare the geo-
metric differences caused by changes in target shape and
location for each tumor: the percentage of overlap volume
(POV), defined as the ratio between the overlapping and
encompassing volume between each pair of ITVs; the geo-
metric missing volume of ITVall for ITVslow; the geomet-
ric coverage of ITV2, ITVslow, and ITV2+slow for ITVall;
and the geometric coverage of ITVall and ITV2+slow for
ITVall+slow. To evaluate the impact of the tumor param-
eters on the volumetric and geometric differences among
the ITVs, the PVD and POV between each pair of ITVs
were correlated with the tumor parameters, such as
the mean GTV and motion range factors (SI, AP, and
LR movement; 3D mobility; and overlap ratio between
the 2 extreme bins). The volumes among ITVs were
also compared in subgroups corresponding to the upper/
middle lobe and the lower lobe, according to the tumor
location.
Dosimetric analysis
Three conformal SBRT plans for all 15 tumors were
performed using 3 ITVs of ITVall, ITVall+slow, and
ITV2+slow to assess the dosimetric effects on a normal
lung resulting from the various target volumes. The
planning target volumes (PTVs) were created by adding
a uniform 5 mm margin to the ITVs. All plans used 10–14
coplanar and/or non-coplanar beams and were normalized
such that at least 95% of the PTV received the prescription
dose. The dose-fractionation schedules were 48 Gy in 4
fractions (13 tumors), 56 Gy in 4 fractions (1 tumor), and
50 Gy in 5 fractions (1 tumor). To provide a meaningful
comparison, the beam energies, weights, and gantry angles
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normal lung of SBRT planning using the 3 different ITVs
were analyzed via lung-dose parameters such as the mean
lung dose (MLD) and the percentage volumes of both lungs
minus the PTV receiving specific doses of 5, 10, 20, 25, and
30 Gy (V5, V10, V20, V25, and V30), as estimated using
dose-volume histograms.
Statistical analysis
To compare the volumetric and geometric differences
between each pair of ITVs and the lung-dose parameters
for the three SBRT plans, we used a Wilcoxon signed-rank
test for each tumor. The correlations between the volumet-
ric and geometric differences and the tumor parameters for
each tumor were evaluated using Spearman correlation
analyses. Values of P < 0.05 were regarded as significant. All
statistical analyses were performed using the SPSS software
package (version 15.0; SPSS Inc., Chicago, IL, USA).
Results
The tumor motions were the most extensive in the SI
(6.2 ± 4.2 mm) direction, approximately 1.6 times greater
than those in the AP (3.9 ± 2.2 mm) and LR (3.7 ± 2.6 mm)
directions. The mean 3D mobility, which was calculated as
(SI2 + AP2 + LR2)1/2, was found to be 8.3 ± 5.2 mm for all
15 tumors, and the tumors exhibited distinct differences in
3D mobility corresponding to their location in the lung.
The 3D mobility for tumors in the upper/middle lobe
(n = 10) was 5.1 ± 2.3 mm, and that for the lower lobe
(n = 5) was 14.7 ± 2.4 mm (p < 0.01). The overlap ratios
between the 2 extreme bins for tumors in the upper/middle
lobe and the lower lobe were 0.65 ± 0.05 and 0.39 ± 0.11,
respectively (p = 0.086).
Table 2 presents the measurements of mean GTV for
the GTVs from all 8 phases and the 5 ITVs generated using
different ITV definitions. On average, the volumes were ob-
tained in the following order: ITVslow (9.7 ± 7.0 cm3) ≈
ITV2 (10.0 ± 7.5 cm3) < ITV2+slow (11.5 ± 8.3 cm3) ≈
ITVall (11.8 ± 8.3 cm3) < ITVall+slow (12.5 ± 8.9 cm3).
Comparisons between each pair of ITVs exhibited statistical
significance (p < 0.01), except between ITV2 and ITVslow
(p = 0.820) and between ITVall and ITV2+slow (p = 0.140).
Interestingly, there was a significant difference between
ITVall and ITVall+slow (p = 0.001), and the PVD between
them was 5.8 ± 3.5% (range: 1.6 – 13.5%). The PVD with
respect to ITVall was decreased by a factor of approxi-
mately 3 for ITV2+slow (5.3 ± 4.8%) compared to the
PVD between ITV2 and ITVall (15.3 ± 6.6%).
In the geometric analyses among the ITVs, a mean of
7.5% (range: 2.0 – 17.6%) of ITVslow was not encom-
passed in ITVall. The geometric coverages of ITV2 (POV
between ITV2 and ITVall) and ITVslow for ITVall were
84.7 ± 6.6% and 76.2 ± 9.3%, respectively. However, the
coverage for ITVall increased to 90.9 ± 5.9% when usingthe composite (ITV2+slow) of these two ITVs (p < 0.01),
and the difference in geometric coverage (POV) for
ITVall+slow between ITVall (94.2 ± 3.5%) and ITV2+slow
(91.5 ± 5.4%) was not significant (p = 0.140) (Figures 1
and 2, Table 3). No PVD or POV between any pair of
ITVs exhibited a significant correlation with tumor pa-
rameters such as the mean GTV or motion range factors.
In addition, the variations in the volumetric differences
among the ITVs for the subgroups of the upper/middle
and lower lobes were not statistically significant.
Among the SBRT plans based on 3 different ITVs, there
were statistically significant increases in the MLD, V5,
V10, V20, V25, and V30 of the plans utilizing ITVall+slow
due to an increase in the target volume compared to the
plans employing ITVall or ITV2+slow. The V20 values for
the plans that used ITVall+slow, ITVall, and ITV2+slow
were 5.10 ± 1.90%, 4.97 ± 1.88%, and 5.00 ± 1.86%, respect-
ively. However, the magnitudes of these differences among
the plans were relatively small, with a value of less than
3% for all dosimetric parameters, and the differences in
lung-dose parameters between the plans that used ITVall
and ITV2+slow were not significant (Table 4).
Discussion
Respiration-induced tumor motion in the lung exhibits
patient-specific patterns and thus is generally difficult to
estimate. However, studies concerning the measurement
of tumor motion in the lung using various methods, in-
cluding 4D CT, commonly report that the largest motions
primarily occur in the SI direction and the lower lobe
[2,3,17]. We also observed greater motion in the SI direc-
tion and the lower lobe, with patient-specific aspects. In
radiotherapy for lung cancer, this type of tumor motion
suggests the need for an individualized margin that con-
siders motions within the patient’s breathing cycle rather
than the application of population-based margins; these
individual approaches are considered to be especially
important for the SBRT technique. Considering the mag-
nitude of tumor mobility, motion-reducing methods such
as gating and abdominal compression can be applied dur-
ing SBRT for lung cancer. However, the most frequently
used technique is the continuous delivery of static beams
under free breathing. When patients breathe freely, the
target volume must be adjusted to completely encompass
the tumor in all phases of the respiratory cycle. However,
the motion-encompassing ITV definitions based on 4D
CT imaging might lead to the use of an unnecessarily
large safety margin during treatment because these
definitions do not consider the fact that the tumor
spends unequal durations in different portions of its
trajectory [4]. More importantly, although breath training,
audio-visual biofeedback, or image-guidance techniques
can be used to ensure regular breathing during CT ac-
quisition and treatment, the single 4D CT scan that is
Table 2 Mean GTV and the 5 ITVs defined for all tumors
Tumor no. Mean GTV (cm3) ITVall (cm3) ITV2 (cm3) ITVslow (cm3) ITVall+slow (cm3) ITV2+slow (cm3)
1 4.9 7.9 6.9 5.1 8.1 7.4
2 11.5 13.8 11.9 12.4 14.2 13.1
3 12.4 23.4 20.6 21.6 25.5 24.4
4 5.2 7.4 6.1 5.8 7.5 6.7
5 1.9 2.8 2.3 2.8 3.2 3.1
6 8.3 14.0 9.1 9.9 15.1 11.5
7 7.6 13.6 11.7 11.9 14.4 13.6
8 2.3 4.0 3.7 3.0 4.1 3.9
9 4.3 8.7 7.0 7.7 10.1 8.9
10 4.7 6.1 5.5 5.8 6.7 6.4
11 9.4 12.3 11.0 10.9 12.9 12.3
12 3.5 6.9 5.5 5.3 7.3 6.2
13 1.3 1.8 1.5 1.4 1.8 1.7
14 16.0 24.0 20.3 15.9 25.6 23.6
15 24.7 30.1 27.5 25.4 31.5 29.5
Mean ± SD 7.9 ± 6.3 11.8 ± 8.3 10.0 ± 7.5 9.7 ± 7.0 12.5 ± 8.9 11.5 ± 8.3
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corresponding to only a few breathing cycles at the
time of CT acquisition. Therefore, ITV methods based
on a single 4D CT scan might underestimate the full
extent of the potential motion during treatment because
they do not reflect the true tumor motion caused by
breathing pattern variations during actual treatment
[4,10]. Before 4D CT was widely adopted in radiother-
apy planning for lung cancer, a slow CT technique with
a scanning time of 4 s per slice was used as a method
of accurately defining moving target volumes, based on
the fact that the breathing period in patients with lung
cancer was no longer than 4 s in most cases. In several
studies, such slow CT scans have been shown to generate
larger and more reproducible target volumes for lung
tumors than fast CT scans, thereby indicating their greater
ability to capture tumor movement [11,18,19]. However,
movement during a long scanning time can lead to ob-
scure images of the tumor and adjacent anatomic struc-
tures, and the loss of resolution caused by such motion
blurring leads to larger observer errors in delineating the
tumor and normal organs [6]. Using a low pitch factor,
slow CT scanning can be effectively performed in a mod-
ern CT scanner, with the limitation of the gantry rotation
time, which is intended for a fast scan speed [16]. Al-
though our modified slow scan differs from the con-
ventional slow CT scanning conducted at 4 s per slice,
the data acquisition time for each slice increased from
0.36 s for our fast CT protocol in the thorax (gantry
rotation time of 0.5 s and pitch of 1.4) to 2.0 s for this
modified slow CT scan. This modified slow CT scan pro-
vides images with a more representative geometry for theentire respiratory cycle, as would occur during treatment,
that can be used as reference images for dose calculation;
this approach minimizes the image blurring observed for
full slow CT scans and provides additional motion infor-
mation that is complementary to the single 4D CT results.
However, a limitation of our methods might be some
exposure by additional CT scan. Regarding to the doses
for these CT scans, the mean values of dose-length pro-
duct (DLP) and effective dose for the 4D CT scan in all
patients were 918.3 ± 111.5 mGy · cm and 12.9 ± 1.6 mSv,
respectively, and additional doses for the modified slow
CT scan were 163.5 ± 17.9 mGy · cm and 2.3 ± 0.3 mSv,
respectively.
In this study, ITVslow was the smallest among all ITVs
and was statistically different from all other ITVs except
ITV2. Thus far, few studies have directly compared the
target volumes determined using slow CT and 4D CT in
the same patients. In a study in which both slow CT
(rotation time of 4 s) and 4D CT were performed using
a 4-slice CT scanner for SBRT of lung tumors [14], no
significant difference in size was found between target
volumes determined using the two CT techniques. How-
ever, the size of the target volume generated from slow
CT was smaller than that generated from all phases of 4D
CT by a mean value of 25%. Furthermore, based on the
results of a group study investigating the difference be-
tween breathing periods of < 4 s and ≥ 4 s, the authors
suggested that the motion patterns of tumors during CT
scanning may be more important than the breathing
period in differentiating these target volumes. In our study
using a modified slow CT scan, the ratio of ITVslow/
ITVall was 0.82 on average, and the PVD between these
Figure 2 Geometric coverages of 3 ITVs for ITVall in a lung cancer patient (tumor No. 10). A. Relationship between ITVall (blue) and ITV2
(yellow), ITVslow (green), and ITV2+slow (red) in coronal views. B. Geometric coverages of ITV2, ITVslow, and ITV2+slow for ITVall.
Figure 1 Example of different ITVs in a lung cancer patient (tumor No. 3). Transverse, sagittal, and coronal views of ITVslow (green), ITVall
(blue), and ITVall+slow (red) are projected onto a modified slow CT scan. A. Delineation of ITVslow. B. Relationship between ITVall and ITVslow.
The geometric regions of ITVslow that are missed by ITVall are displayed as green colored regions. C. Relationship between ITVall and ITVall+slow.
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Table 3 Geometric coverage between ITVs based on different ITV definitions
Tumor no. Coverage (%) for ITVall Coverage (%) for ITVall+slow Coverage (%) for ITVslow
ITV2 ITVslow ITV2+slow ITVall ITV2+slow ITVall
1 86.6 61.7 90.2 97.5 90.4 96.0
2 85.7 87.6 92.0 97.8 92.2 97.5
3 88.1 83.6 95.4 91.9 95.7 90.5
4 83.4 77.5 88.9 98.4 89.0 98.0
5 80.2 86.2 95.0 88.4 95.5 86.9
6 65.3 62.7 74.2 92.8 76.1 89.0
7 86.3 81.5 93.6 94.1 94.0 92.9
8 91.9 71.6 95.6 97.3 95.7 96.4
9 79.9 72.9 86.4 86.5 88.2 82.4
10 89.8 85.9 95.9 91.8 96.2 90.6
11 90.1 84.0 95.2 95.0 95.4 94.1
12 80.4 70.2 83.3 93.8 84.4 91.4
13 87.2 78.6 93.0 97.9 93.0 97.5
14 84.6 59.7 91.8 93.6 92.3 89.8
15 91.1 79.6 93.4 95.5 93.7 94.5
Mean ± SD 84.7 ± 6.6 76.2 ± 9.3 90.9 ± 5.9 94.2 ± 3.5 91.5 ± 5.4 92.5 ± 4.4
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cant difference in the ITV sizes obtained with the two
different CT techniques. This difference may be a result of
the smaller target volume in this slow CT technique, as
the tumor motions over the full respiratory cycle at each
couch position could not be adequately covered because
of the faster scan speed compared to the conventional
slow CT speed of 4 s per slice. Another possible explan-
ation is that the difference may result from a change in
tumor motion caused by breathing pattern variations be-
tween the two CT techniques; the possibility of such an
effect was suggested by Nakamura et al. [14]. In addition
to this volumetric difference, our observation about the
geometric coverage between ITVslow and ITVall is con-
sistent with those reported by Nakamura et al. [14], who
found that a mean of 8% of the target volume derived
from slow CT was not encompassed in the target volume
derived from all phases of 4D CT. Based on this geometricTable 4 Differences in lung-dose parameters for SBRT plans b
Parameters ITVall+slow ITVall ITV2+slow ITVall+slow
(Mean ± SD) (Mean ± SD) (Mean ± SD) Mean (rang
MLD (cGy) 357.3 ± 89.7 351.6 ± 89.6 353.1 ± 88.1 5.8 (−1.2-33
V5 (%) 17.05 ± 3.90 16.88 ± 3.88 16.94 ± 3.87 0.18 (−0.07-1
V10 (%) 11.77 ± 2.98 11.57 ± 2.94 11.67 ± 2.98 0.20 (−0.05-1
V20 (%) 5.10 ± 1.90 4.97 ± 1.88 5.00 ± 1.86 0.14 (0.00-0
V25 (%) 3.37 ± 1.37 3.28 ± 1.37 3.29 ± 1.31 0.09 (−0.01-0
V30 (%) 2.28 ± 0.98 2.22 ± 0.98 2.22 ± 0.93 0.06 (0.00-0
*Wilcoxon signed-rank test.difference between the ITVs generated from 4D CT and
modified slow CT, ITVall was significantly smaller than
ITVall+slow. In a recent study, Ge et al. [15] compared
volumetric differences among ITVs based on 4DCT, in-
cluding a method that used a GTV contoured on a fast 3D
CT image (GTV3D) in lung cancer patients treated with
SBRT. In this research, the ITV generated by all 10 phases
of 4DCT (ITV10phase) and the ITV generated by com-
bining ITV10phase and GTV3D were 14.7 cc and 15.9 cc,
respectively, indicating a significant volumetric difference.
The authors also suggested that individualized ITV’s
uncertainties could be minimized by combining target
volumes generated from 4D CT and fast 3D CT. Cur-
rently, ITV methods using a single 4D CT scan, which is
considered the gold standard for SBRT planning, might
underestimate the true tumor motion during treatment
due to possible variations in breathing patterns between
the planning CT acquisition and treatment [4,10], but thisased on 3 different ITVs
vs. ITVall ITVall+slow vs. ITV2+slow ITVall vs. ITV2+slow
e) p* Mean (range) p* Mean (range) p*
.9) 0.001 4.3 (0.1-13.5) 0.001 −1.5 (−33.8-12.3) 0.887
.04) 0.011 0.11 (−0.01-0.47) 0.001 −0.06 (−1.04-0.54) 0.910
.38) 0.008 0.10 (0.01-0.23) 0.001 −0.10 (−1.37-0.17) 0.820
.86) 0.001 0.10 (0.00-0.30) 0.001 −0.03 (−0.85-0.24) 0.776
.55) 0.001 0.09 (0.00-0.37) 0.001 0.00 (−0.55-0.30) 0.496
.37) 0.001 0.06 (0.00-0.27) 0.001 0.00 (−0.38-0.21) 0.496
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addition of motion information from an additional CT
technique.
The clinical workload involved in contouring on all
8–10 bins within the breathing cycle can be reduced by
the tools using the MIP or only the 2 extreme phases of
4D CT [4,9]. However, the value of MIP scans is limited
in cases where the tumor is adjacent to normal structures,
such as the chest wall or mediastinum and MIP-based
ITVs tend to underestimate the true tumor motion in
comparison to ITVs that use all phases of the respiratory
cycle [20,21]. When the magnitude of the motion is small
compared to the tumor size, the range of motion can be
effectively contoured using only the 2 extreme phases.
However, in the case of small highly mobile tumors,
intermediate tumor positions are required to generate a
reliable ITV [4,9]. In our study on the use of 2 extreme
phases, the geometric coverage of ITV2 for ITVall was
84.7%. Other studies concerning target volumes have
employed only the 2 extreme phases of 4D CT. Ezhil
et al. [21] reported results similar to ours in 17 patients
with stage I lung tumor; they found that the ITVs based
on the 2 extreme phases covered 83.9% of the ITVs gener-
ated from all 10 phases. Furthermore, Rietzel et al. [22]
reported that 10 patients with stage I-III lung cancer ex-
hibited a 93.7% overlap between the PTVs generated from
only 2 extreme tumor positions compared to those gener-
ated from 10 respiratory phases. Our study also exhibited
an increased value of 90.8% when comparing the overlap
between 2 such PTVs after adding a uniform 5 mm setup
margin to the 2 ITVs, and these volumetric and geometric
differences with respect to ITVall were decreased by
combining ITV2 and ITVslow, indicating that there is
no significant volumetric difference between ITVall and
ITV2+slow. Therefore, this composite ITV using 2 extreme
phases and a modified slow scan may be useful for more
accurate target delineation compared to the ITV method
alone using 2 extreme phases. In particular, this composite
method may be helpful for constructing more reliable ITVs
for small and highly mobile tumors. Using correlation and
subgroup analyses, we found that the volumetric and geo-
metric differences among the ITVs exhibited consistent
results for all tumors, regardless of tumor parameters such
as the mean GTV, location, or motion range factors. This
finding indicates that the respiratory tumor motions were
sufficiently reflected by ITV2 and ITVslow, which may
differ from the target volumes generated using fast CT or
the end-exhalation phase. Indeed, the correlations for the
PVD and POV between ITVall and ITVslow with respect
to the 3D mobility were not significant.
Recent studies have suggested that the MLD and the
percentage of total lung volume receiving a specific dose
can serve as the main dosimetric predictors of symptom-
atic radiation pneumonitis after SBRT. For MLD ≤ 5 Gyand/or V20 ≤ 5-10%, the risk of grade ≥ 2 radiation pneu-
monitis found in most studies is only 10-15% [23-26]. In
our results regarding dosimetry on a normal lung with
respect to the variations in the derived ITVs, the values of
lung-dose parameters were significantly increased in the
plans based on ITVall+slow in comparison to the plans
based on ITVall or ITV2+slow, but the magnitudes of
these differences among plans were relatively small.
Therefore, considering the possible error in true target
delineation caused by breathing pattern variations and
the small dosimetric difference in normal lung tissue
caused by the increased target volume, the target volume
definition obtained by combining 4D CT and a modified
slow CT scan may be preferable to that obtained using a
single 4D CT scan.Conclusions
We found that ITV delineation based solely on 4D CT
and that based on 4D CT plus a modified slow CT scan
were significantly different in volumetric and geometric
comparisons. The combination of 4D CT and a modified
slow CT scan in SBRT planning for lung cancer can be
used to reduce possible errors in true target delineation
caused by breathing pattern variations, as this approach
provides additional motion information. ITV delineation
using only the 2 extreme phases of 4D CT plus a modified
slow CT scan may be appropriate as a strategy for re-
ducing the clinical workload, as this method generates
a more reliable ITV than techniques utilizing only the
2 extreme phases of 4D CT.
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